Biora Therapeutics, Inc.
BIOR · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$124,115 | -$38,157 | -$178,521 | -$192,528 |
| Dep. & Amort. | $555 | $907 | $1,437 | $1,438 |
| Deferred Tax | $0 | $0 | $21,928 | $58,571 |
| Stock-Based Comp. | $16,475 | $7,804 | $11,962 | $8,244 |
| Change in WC | $8,617 | -$4,650 | -$25,864 | -$51,170 |
| Other Non-Cash | $49,969 | -$30,321 | $1,572 | $9,701 |
| Operating Cash Flow | -$48,499 | -$64,417 | -$167,486 | -$165,744 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$103 | -$792 | -$855 | -$4,944 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $2,546 | $0 | -$387 | $0 |
| Investing Cash Flow | $2,443 | -$792 | -$1,242 | -$4,944 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $10,000 | -$12 | -$1,643 | $98,972 |
| Stock Issued | $18,137 | $9,014 | $46,776 | $116,435 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $2,644 | -$1,704 | $119,916 | $14,315 |
| Financing Cash Flow | $30,781 | $7,298 | $165,049 | $229,722 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$15,275 | -$57,911 | -$3,679 | $59,034 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $30,486 | $88,397 | $92,076 | $33,042 |
| End Cash | $15,211 | $30,486 | $88,397 | $92,076 |
| Free Cash Flow | -$48,602 | -$65,209 | -$168,341 | -$170,688 |